A share price of AMGEN Inc. [AMGN] is currently trading at $319.73, down -0.18%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AMGN shares have gain 2.20% over the last week, with a monthly amount drifted -3.26%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
AMGEN Inc. [NASDAQ: AMGN] stock has seen the most recent analyst activity on September 27, 2024, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $405. Previously, Wells Fargo downgraded its rating to Equal Weight on August 07, 2024, and elevated its price target to $335. On May 03, 2024, upgrade upgraded it’s rating to Outperform. Barclays upgraded its rating to a Equal Weight and increased its price target to $300 on May 03, 2024. Leerink Partners downgraded its rating to Market Perform for this stock on February 07, 2024, and downed its price target to $318. In a note dated December 21, 2023, Daiwa Securities upgraded an Buy rating on this stock and boosted its target price from $264 to $320.
AMGEN Inc. experienced fluctuations in its stock price throughout the past year between $249.70 and $346.85. Currently, Wall Street analysts expect the stock to reach $286.05 within the next 12 months. AMGEN Inc. [NASDAQ: AMGN] shares were valued at $319.73 at the most recent close of the market. An investor can expect a potential drop of -10.53% based on the average AMGN price forecast.
Analyzing the AMGN fundamentals
Trailing Twelve Months sales for AMGEN Inc. [NASDAQ:AMGN] were 30.74B which represents 19.90% growth. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.2%, Pretax Profit Margin comes in at 0.11%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.5 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 10.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 317.05 points at the first support level, and at 314.37 for the second support level. However, for the 1st resistance point, the stock is sitting at 321.54, and for the 2nd resistance point, it is at 323.35.
Ratios To Look Out For
To put it in perspective, the Current Ratio for AMGEN Inc. [NASDAQ:AMGN] is 1.26. Further, the Quick Ratio stands at 0.89, while the Cash Ratio is 0.43. Considering the valuation of this stock, the price to sales ratio is 5.59, the price to book ratio is 28.99 and price to earnings (TTM) ratio is 55.09.
Transactions by insiders
Recent insider trading involved Grygiel Nancy A., SVP & CCO, that happened on May 03 ’24 when 2117.0 shares were sold. SVP & CCO, Grygiel Nancy A. completed a deal on Dec 04 ’23 to sell 2096.0 shares. Meanwhile, EVP, Gen. Counsel & Secy. Graham Jonathan P sold 10000.0 shares on Nov 08 ’23.
